Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Glioblastoma cells can make androgens, which might help the tumor grow.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Certain pesticides and fungicides can interfere with male hormone functions, potentially causing reproductive issues in male rats.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

New compounds were made that are promising for prostate cancer therapy.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Targeting Sirt1 can reduce androgen levels and slow glioblastoma growth.

Excess androgens may cause PCOS, not just be a symptom.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Androgens don't directly affect hair cell growth or protein production.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.